ХАРАКТЕР ВЗАИМОДЕЙСТВИЯ БАКТЕРИЙ-КОММЕНСАЛОВ С ФАКТОРАМИ ИММУНИТЕТА ПРИ НЕКОТОРЫХ СИНДРОМАХ ХРОНИЧЕСКОГО ВОСПАЛЕНИЯ КИШЕЧНИКА
- Авторы: Бехало ВА1, Бондаренко ВМ1, Сысолятина ЕВ1, Bechalo VA2, Bondarenko VM2, Sisolyatina EV2
-
Учреждения:
- НИИ эпидемиологии и микробиологии им. Н.Ф. Гамалеи РАМН, Москва
- Выпуск: № 13 (2009)
- Страницы: 20-25
- Раздел: Статьи
- URL: https://journals.eco-vector.com/2073-4034/article/view/277431
- ID: 277431
Цитировать
Полный текст
Аннотация
Об авторах
В А Бехало
НИИ эпидемиологии и микробиологии им. Н.Ф. Гамалеи РАМН, МоскваНИИ эпидемиологии и микробиологии им. Н.Ф. Гамалеи РАМН, Москва
В М Бондаренко
НИИ эпидемиологии и микробиологии им. Н.Ф. Гамалеи РАМН, МоскваНИИ эпидемиологии и микробиологии им. Н.Ф. Гамалеи РАМН, Москва
Е В Сысолятина
НИИ эпидемиологии и микробиологии им. Н.Ф. Гамалеи РАМН, МоскваНИИ эпидемиологии и микробиологии им. Н.Ф. Гамалеи РАМН, Москва
V A Bechalo
V M Bondarenko
E V Sisolyatina
Список литературы
- Pickard KM, Brenner AN, Gordon JN, et al. Microbial-gut interactions in health and disease. Immune responses. Вest Pract Res Clin Gastrоenterol 2004;18(2):271-85.
- Rakoff-Nahoum S, Paglino J, Esmali-Varzaeh F, et al. Recognition of commensal microflora by toll-like receptors for intestinal homeostasis. Cell 2004;118(2):229-41.
- Ковальчук Л.В. Учение о воспалении в свете новых данных: развитие идей И.И. Мечникова // Микробиология. 2008. № 5. С. 10-5.
- Acheson DW, Luccioli S. Microbial-gut interactions in health and disease. Mucosal immune responses. Best Pract Res Clin Gastroenterol 2004;18:387-404.
- Sansonetti PJ. War and peace at mucosal surfaces. Nat Rev Immunol 2004;4:953-64.
- Рябиченко Е.В., Бондаренко В.М. Роль кишечной бактериальной аутофлоры и ее эндотоксина в патологии человека // Микробиология. 2007. № 3. С. 103-11.
- Бондаренко В.М. Роль условно-патогенных бактерий кишечника в полиорганной патологии человека. М. 2007.
- Ceponis PJ, Botelho F, Richards CD, et al. Interleukins 4 and 13 increase intestinal epithelial permeability by a phosphatidylinositol 3-kinase pathway. Lack of evidence for STAT 6 involvement. J Biol Chem 2005;275:2913-17.
- Madsen KL, Lewis SA, Tavernini MM, et al. Interleukin 10 prevents cytokine-induced disruption of T84 monolayer barrier integrity and limits chloride secretion. Gastroenterology 1997;113:151-59.
- Бондаренко В.М., Виноградов Н.А., Малеев В.В. Антимикробная активность окиси азота и ее роль в инфекционном процессе // Микробиология. 1999. № 5. С. 61-7.
- Chavez AM, Menconi MJ, Hodin RA, et al. Cytokine-induced intestinal epithelial hyperpermeability: role of nitric oxide. Crit Care Med 1999;27:2246-51.
- Han X, Fink MP, Delude RL, et al. Proinflammatory cytokines cause NO-dependent and independent changes in expression and localization of tight junction proteins in intestinal epithelial cells. Shock 2003;19:229-37.
- Broad A, Jones DE, Kirby JA. Toll-like receptor (TLR) response tolerance: a key physiological "damage limitation" effect and an important potential opportunity for therapy. Curr Med Chem 2006;13(21):2487-502.
- Philpott DJ, Girardin SE. The role of tall-like receptors and Nod proteins in bacterial infection. Mol Immunol 2004;41:1099-108.
- Macdonald TT, Monteleone G. Immunity, inflammation, and allergy in the gut. Science 2005;307:1920-25.
- Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001;1(2):143-45.
- Mack DR, Ahrne S, Hude L, et al. Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut 2003;52:827-33.
- Clark JA, Coopersmith CM. Intestinal crosstalk - a new paradigm for understanding the gut as the "motor" of critical illness. Shock 2007;28(4):384-93.
- Hooper LV, Stappenbeck TS, Hong CV, et al. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat Immunol 2003;4:269-73.
- Jobin C, Sartor RB. The IkB/NFkB system: a key determinant of mucosal inflammation and protection. Am J Physiol 2000;278:451-62.
- Campbell DJ, Kim CH, Butcher EC. Chemokines in the systemic organization of immunity. Immunol Rev 2003;195:58-71.
- Лазебник ЛБ, Дроздов В.Н. и др. Оксид азота как маркер воспаления при неспецифическом язвенном колите и болезни Крона // Экспериментальная клиническая гастроэнтерология. 2006. № 3. С. 4-8.
- Marcinkiewicz J, Chain B, Nowak B, et al. Antimicrobial and cytotoxic activity of hypochlorous acid: interactions with taurine and nitrite. Inflam Res 2000;49:280-89.
- Guigot G, Guimbaud R, Bertrand V, et al. Inducible nitric oxide synthase activity in colon biopsies from inflammatory areas: correlation with inflammation intensity in patients with ulcerative colitis but not with Crohn's disease. Amino Acids 2000;18:229-35.
- Kolios G, Rooney N, Murthy CT, et al. Expression if inducible nitric oxide synthase activity in human colon epithelial cells: modulation by T-lymphocyte derived cytokines. Gut 1998;43:56-63.
- McCafferty DM. Peroxynitrite and inflammatory bowel disease. Gut 2000;46:436-39.
- Kharitonov SA, Yates DH, Barnes PJ. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 1996;153:454-57.
- Grabowski PS, Macpherson H, Ralston SH. Nitric oxide production in cells derived from the human joint. Br J Rheumatol 1996;35:207-12.
- Abe T, Hikiji H, Shin WS, et al. Targeting of iNOS with antisense DNA plasmid reduces cytokine-induced ingibition of osteoblastic activity. Am J Physiol Endocrinol Metab 2003;285:E614-E621.
- Grisham MB, Pavlick KP, Laroux FS, et al. Nitric oxide and chronic gut inflammation: controverde in inflammatory bowel disease. J Invest Med 2002;50:272-83.
- Zandecki M, Raeymaekers P, Janssens J et al. The effect of nitric oxide donors on nitric oxide synthase-expressing mesenteric neurons in culture. Neurogastroenterol Motil 2006;18:307-15.
- Porras M, Martin MT, Teran E, et al. The nitric oxide donor LA-419 [S-(6-nitro-oxi-hexahydrofuro-furan-tioacetate] prevents intestinal dysmotility, bacterial translocation, and inflammation in a rat model of enteritis. JPET 2008;324:740-8.
- Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nature Rev Immunol 2003;3:521-33.
- Manichanh C, Rigottier-Gois L, Bonnaud E, et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 2006;55:205-11.
- Conte MP, Schippa S, Zamboni I, et al. Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut 2006;55:1760-67.
- Klessen B, Kroesen AJ, Buhr HJ, et al. Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand J Gastroenterol 2002;37:1034-41.
- Lepage P, Seksik P, Sutren M, et al. Biodiversity of the mucosa-associated microbiota is stable along the distal digestive tract in healthy individuals and patients with IBD. Inflamm Bowel Dis 2005;11:473-80.
- Vandenbroucke K, Hans W, Van Huysse, et al. Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice. Gastroenterology 2004;127:502-13.
- Clavel T, Haller D. Molecular interactions between bacteria, the epithelium, and the mucosal immune system in the intestinal tract: implications for chronic inflammation. Curr Issues Intestinal Microbiol 2007;8:25-43.
- Морозова Н.А., Белоусова Е.А., Великанов Е.В. и др. Применение азатиоприма при рефрактерном язвенном колите: зарубежные данные и собственный опыт // Фарматека. 2007. № 2. С. 27-30.